These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20520300)

  • 21. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
    Rittmannsberger H
    Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
    Leblhuber F; Reisecker F; Bengesser G
    Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of tardive dyskinesia.
    Kane JM; Woerner M; Lieberman JA; Weinhold P; Florio W; Rubinstein M; Rotrosen J; Kurucz J; Mukherjee S; Bergmann K
    Psychopharmacol Bull; 1985; 21(1):136-9. PubMed ID: 2858906
    [No Abstract]   [Full Text] [Related]  

  • 25. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam in tardive dyskinesia: an open label study.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of akathisia with lorazepam. An open clinical trial.
    Bartels M; Heide K; Mann K; Schied HW
    Pharmacopsychiatry; 1987 Mar; 20(2):51-3. PubMed ID: 2884681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in tardive dyskinesia and MMPI scores with propranolol.
    Novac A
    J Clin Psychiatry; 1986 Apr; 47(4):218-9. PubMed ID: 3957889
    [No Abstract]   [Full Text] [Related]  

  • 30. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 31. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of tardive dyskinesia with lecithin.
    Jackson IV; Nuttall EA; Ibe IO; Perez-Cruet J
    Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset and course of tardive dyskinesia.
    Munetz MR; Toenniessen L; Scala C; Reiss DJ
    Psychosomatics; 1989; 30(3):346-8. PubMed ID: 2569752
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of tardive syndromes with clozapine: a case series.
    Grover S; Hazari N; Kate N; Chakraborty K; Sharma A; Singh D; Gupta J; Lahariya S
    Asian J Psychiatr; 2014 Apr; 8():111-4. PubMed ID: 24655641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic-induced respiratory dyskinesia.
    Kruk J; Sachdev P; Singh S
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):223-9. PubMed ID: 7626967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine-induced tardive dystonia (blepharospasm).
    Duggal HS; Mendhekar DN
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):86-7. PubMed ID: 17308236
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of clozapine on tardive dyskinesia.
    Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients.
    Sweet RA; Mulsant BH; Rifai AH; Zubenko GS
    J Geriatr Psychiatry Neurol; 1992; 5(3):156-61. PubMed ID: 1353963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.